Expression and translation of the COX-1b gene in human cells – no evidence of generation of COX-1b protein

References

Bendtsen, J.D., Nielsen, H., von Heijne, G., and Brunak, S. (2004). Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340, 783–795.10.1016/j.jmb.2004.05.028Search in Google Scholar

Censarek, P., Freidel, K., Udelhoven, M., Ku, S.J., Hohlfeld, T., Meyer-Kirchrath, J., Schrör, K., and Weber, A.A. (2004). Cyclooxygenase COX-2a, a novel COX-2 mRNA variant, in platelets from patients after coronary artery bypass grafting. Thromb. Haemost. 92, 925–928.10.1160/TH04-05-0302Search in Google Scholar

Censarek, P., Freidel, K., Hohlfeld, T., Schrör, K., and Weber, A.A. (2006). Human cyclooxygenase-1b is not the elusive target of acetaminophen. Eur. J. Pharmacol. 551, 50–53.10.1016/j.ejphar.2006.08.079Search in Google Scholar

Chandrasekharan, N.V., Dai, H., Roos, K.L., Evanson, N.K., Tomsik, J., Elton, T.S., and Simmons, D.L. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl. Acad. Sci. USA 99, 13926–13931.10.1073/pnas.162468699Search in Google Scholar

Cui, J.G., Kuroda, H., Chandrasekharan, N.V., Pelaez, R.P., Simmons, D.L., Bazan, N.G., and Lukiw, W.J. (2004). Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells. Neurochem. Res. 29, 1731–1737.10.1023/B:NERE.0000035809.70905.8aSearch in Google Scholar

Dinchuk, J.E., Liu, R.Q., and Trzaskos, J.M. (2003). COX-3: in the wrong frame in mind. Immunol. Lett. 86, 121.10.1016/S0165-2478(02)00268-7Search in Google Scholar

Emanuelsson, O., Brunak, S., von Heijne, G., and Nielsen, H. (2007). Locating proteins in the cell using TargetP, SignalP and related tools. Nat. Protoc. 2, 953–971.10.1038/nprot.2007.131Search in Google Scholar PubMed

Graham, G.G. and Scott, K.F. (2005). Mechanism of action of paracetamol. Am. J. Ther. 12, 46–55.10.1097/00045391-200501000-00008Search in Google Scholar PubMed

Ivanov, I.P., Gesteland, R.F., Matsufuji, S., and Atkins, J.F. (1998). Programmed frameshifting in the synthesis of mammalian antizyme is +1 in mammals, predominantly +1 in fission yeast, but -2 in budding yeast. RNA 4, 1230–1238.10.1017/S1355838298980864Search in Google Scholar PubMed PubMed Central

Kam, P.C.A. and So, A. (2009). COX-3: uncertainties and controversies. Curr. Anaesth. Crit. Care 20, 50–53.10.1016/j.cacc.2008.11.003Search in Google Scholar

Kis, B., Snipes, J.A., Isse, T., Nagy, K., and Busija, D.W. (2003). Putative cyclooxygenase-3 expression in rat brain cells. J. Cereb. Blood Flow Metab. 23, 1287–1292.10.1097/01.WCB.0000090681.07515.81Search in Google Scholar PubMed

Kis, B., Snipes, J.A., Gaspar, T., Lenzser, G., Tulbert, C.D., and Busija, D.W. (2006). Cloning of cyclooxygenase-1b (putative COX-3) in mouse. Inflamm. Res. 55, 274–278.10.1007/s00011-006-0083-zSearch in Google Scholar PubMed

Klamp, T., Sahin, U., Kyewski, B., Schwendemann, J., Dhaene, K., and Türeci, O. (2006). Expression profiling of autoimmune regulator AIRE mRNA in a comprehensive set of human normal and neoplastic tissues. Immunol. Lett. 106, 172–179.10.1016/j.imlet.2006.06.006Search in Google Scholar PubMed

Moon, S., Byun, Y., Kim, H.J., Jeong, S., and Han, K. (2004). Predicting genes expressed via -1 and +1 frameshifts. Nucleic. Acid. Res. 32, 4884–4892.10.1093/nar/gkh829Search in Google Scholar PubMed PubMed Central

Nurmi, J.T., Puolakkainen, P.A., and Rautonen, N.E. (2005). Intron 1 retaining cyclooxygenase 1 splice variant is induced by osmotic stress in human intestinal epithelial cells. Prostaglandins Leukot. Essent. Fatty Acids 73, 343–350.10.1016/j.plefa.2005.07.004Search in Google Scholar PubMed

Qin, N., Zhang, S.P., Reitz, T.L., Mei, J.M., and Flores, C.M. (2005). Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention. J. Pharmacol. Exp. Ther. 315, 1298–1305.10.1124/jpet.105.090944Search in Google Scholar PubMed

Reeder, J. and Giegerich, R. (2004). Design, implementation and evaluation of a practical pseudo-knot algorithm based on thermodynamics. BMC Bioinformatics. 5, 104.10.1186/1471-2105-5-104Search in Google Scholar PubMed PubMed Central

Schaefer, H., Chervet, J.P., Bunse, C., Joppich, C., Meyer, H.E., and Marcus, K.A. (2004). Peptide preconcentration approach for nano-high-performance liquid chromatography to diminish memory effects. Proteomics 4, 2541–2544.10.1002/pmic.200300801Search in Google Scholar PubMed

Schwab, J.M., Beiter, T., Linder, J.U., Laufer, S., Schulz, J.E., Meyermann, R., and Schluesener, H.J. (2003). COX-3 – a virtual pain target in humans? FASEB J. 17, 2174–2175.Search in Google Scholar

Simmons, D.L., Botting, R.M., and Hla, T. (2004). Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 56, 387–437.10.1124/pr.56.3.3Search in Google Scholar PubMed

Snipes, J.A., Kis, B., Shelness, G.S., Hewett, J.A., and Busija, D.W. (2005). Cloning and characterization of cyclooxygenase-1b (putative cyclooxygenase-3) in rat. J. Pharmacol. Exp. Ther. 313, 668–676.10.1124/jpet.104.079533Search in Google Scholar PubMed

Willoughby, D.A., Moore, A.R., and Colville-Nash, P.R. (2000). COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 355, 646–648.10.1016/S0140-6736(99)12031-2Search in Google Scholar

Wills, N.M. and Atkins, J.F. (2006). The potential role of ribosomal frameshifting in generating aberrant proteins implicated in neurodegenerative diseases. RNA 12, 1149–1153.10.1261/rna.84406Search in Google Scholar PubMed PubMed Central